慢性閉塞性肺疾患(COPD)治療の世界市場:規模・現状・予測2019-2025

【英語タイトル】Global Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size, Status and Forecast 2019-2025

QYResearchが出版した調査資料(QYR20FB14393)・商品コード:QYR20FB14393
・発行会社(調査会社):QYResearch
・発行日:2019年11月(※2024年版があります。お問い合わせください)
・ページ数:95
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール(受注後3営業日)
・調査対象地域:グローバル
・産業分野:医療・製薬
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,900 ⇒換算¥577,200見積依頼/購入/質問フォーム
Multi User(5名様閲覧用)USD5,850 ⇒換算¥865,800見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD7,800 ⇒換算¥1,154,400見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
※当調査レポートでは、慢性閉塞性肺疾患(COPD)治療の世界市場について調査・分析し、慢性閉塞性肺疾患(COPD)治療の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別(コルチコステロイド、ホスホジエステラーゼ4型阻害剤、気管支拡張剤、その他)、用途別(病院、診療所、小売薬局、その他)、地域別(北米、ヨーロッパ、中国、日本国内、東南アジア、インド、中南米)に区分して市場規模を算出しました。


・レポートの概要
・世界の慢性閉塞性肺疾患(COPD)治療市場動向
・主要企業別マーケットシェア
・慢性閉塞性肺疾患(COPD)治療の種類別市場規模2014-2019
(コルチコステロイド、ホスホジエステラーゼ4型阻害剤、気管支拡張剤、その他)
・慢性閉塞性肺疾患(COPD)治療の用途別市場規模2014-2019
(病院、診療所、小売薬局、その他)
・慢性閉塞性肺疾患(COPD)治療の北米市場:主要企業・種類別/用途別市場規模
・慢性閉塞性肺疾患(COPD)治療のヨーロッパ市場:主要企業・種類別/用途別市場規模
・慢性閉塞性肺疾患(COPD)治療の中国市場:主要企業・種類別/用途別市場規模
・慢性閉塞性肺疾患(COPD)治療の日本国内市場:主要企業・種類別/用途別市場規模
・慢性閉塞性肺疾患(COPD)治療の東南アジア市場:主要企業・種類別/用途別市場規模
・慢性閉塞性肺疾患(COPD)治療のインド市場:主要企業・種類別/用途別市場規模
・慢性閉塞性肺疾患(COPD)治療の中南米市場:主要企業・種類別/用途別市場規模
・主要企業のプロフィール
(AstraZeneca、Boehringer Ingelheim International GmbH、GlaxoSmithKline、Novartis AG、Teva Pharmaceutical Industries、Sunovion Pharmaceuticals、CHIESI Farmaceutici、Orion Corporation、​Mylan)
・慢性閉塞性肺疾患(COPD)治療の市場規模予測2019-2025
(種類別、用途別、地域別市場予測)
・アナリストの観点・結論
...
【レポートの概要】

In 2018, the global Chronic Obstructive Pulmonary Disease (COPD) Treatment market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.
This report focuses on the global Chronic Obstructive Pulmonary Disease (COPD) Treatment status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Chronic Obstructive Pulmonary Disease (COPD) Treatment development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.

The key players covered in this study
AstraZeneca
Boehringer Ingelheim International GmbH
GlaxoSmithKline
Novartis AG
Teva Pharmaceutical Industries
Sunovion Pharmaceuticals
CHIESI Farmaceutici
Orion Corporation
​Mylan

Market segment by Type, the product can be split into
Corticosteroids
Phosphodiesterase Type 4 Inhibitors
Bronchodilators
Others

Market segment by Application, split into
Hospital
Clinic
Retail Pharmacies
Other

Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Chronic Obstructive Pulmonary Disease (COPD) Treatment status, future forecast, growth opportunity, key market and key players.
To present the Chronic Obstructive Pulmonary Disease (COPD) Treatment development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Chronic Obstructive Pulmonary Disease (COPD) Treatment are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

【レポートの目次】

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size Growth Rate by Type (2014-2025)
1.4.2 Corticosteroids
1.4.3 Phosphodiesterase Type 4 Inhibitors
1.4.4 Bronchodilators
1.4.5 Others
1.5 Market by Application
1.5.1 Global Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Share by Application (2019-2025)
1.5.2 Hospital
1.5.3 Clinic
1.5.4 Retail Pharmacies
1.5.5 Other
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size
2.2 Chronic Obstructive Pulmonary Disease (COPD) Treatment Growth Trends by Regions
2.2.1 Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size by Regions (2019-2025)
2.2.2 Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis

3 Market Share by Key Players
3.1 Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size by by Players
3.1.1 Global Chronic Obstructive Pulmonary Disease (COPD) Treatment Revenue by by Players (2014-2019)
3.1.2 Global Chronic Obstructive Pulmonary Disease (COPD) Treatment Revenue Market Share by by Players (2014-2019)
3.1.3 Global Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Concentration Ratio (CR5 and HHI)
3.2 Chronic Obstructive Pulmonary Disease (COPD) Treatment Key Players Head office and Area Served
3.3 Key Players Chronic Obstructive Pulmonary Disease (COPD) Treatment Product/Solution/Service
3.4 Date of Enter into Chronic Obstructive Pulmonary Disease (COPD) Treatment Market
3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application
4.1 Global Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size by Type (2014-2019)
4.2 Global Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size by Application (2014-2019)

5 North America
5.1 North America Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size (2014-2019)
5.2 Chronic Obstructive Pulmonary Disease (COPD) Treatment Key Players in North America
5.3 North America Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size by Type
5.4 North America Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size by Application

6 Europe
6.1 Europe Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size (2014-2019)
6.2 Chronic Obstructive Pulmonary Disease (COPD) Treatment Key Players in Europe
6.3 Europe Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size by Type
6.4 Europe Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size by Application

7 China
7.1 China Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size (2014-2019)
7.2 Chronic Obstructive Pulmonary Disease (COPD) Treatment Key Players in China
7.3 China Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size by Type
7.4 China Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size by Application

8 Japan
8.1 Japan Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size (2014-2019)
8.2 Chronic Obstructive Pulmonary Disease (COPD) Treatment Key Players in Japan
8.3 Japan Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size by Type
8.4 Japan Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size by Application

9 Southeast Asia
9.1 Southeast Asia Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size (2014-2019)
9.2 Chronic Obstructive Pulmonary Disease (COPD) Treatment Key Players in Southeast Asia
9.3 Southeast Asia Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size by Type
9.4 Southeast Asia Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size by Application

10 India
10.1 India Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size (2014-2019)
10.2 Chronic Obstructive Pulmonary Disease (COPD) Treatment Key Players in India
10.3 India Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size by Type
10.4 India Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size by Application

11 Central & South America
11.1 Central & South America Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size (2014-2019)
11.2 Chronic Obstructive Pulmonary Disease (COPD) Treatment Key Players in Central & South America
11.3 Central & South America Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size by Type
11.4 Central & South America Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size by Application

12 International Players Profiles
12.1 AstraZeneca
12.1.1 AstraZeneca Company Details
12.1.2 Company Description and Business Overview
12.1.3 Chronic Obstructive Pulmonary Disease (COPD) Treatment Introduction
12.1.4 AstraZeneca Revenue in Chronic Obstructive Pulmonary Disease (COPD) Treatment Business (2014-2019))
12.1.5 AstraZeneca Recent Development
12.2 Boehringer Ingelheim International GmbH
12.2.1 Boehringer Ingelheim International GmbH Company Details
12.2.2 Company Description and Business Overview
12.2.3 Chronic Obstructive Pulmonary Disease (COPD) Treatment Introduction
12.2.4 Boehringer Ingelheim International GmbH Revenue in Chronic Obstructive Pulmonary Disease (COPD) Treatment Business (2014-2019)
12.2.5 Boehringer Ingelheim International GmbH Recent Development
12.3 GlaxoSmithKline
12.3.1 GlaxoSmithKline Company Details
12.3.2 Company Description and Business Overview
12.3.3 Chronic Obstructive Pulmonary Disease (COPD) Treatment Introduction
12.3.4 GlaxoSmithKline Revenue in Chronic Obstructive Pulmonary Disease (COPD) Treatment Business (2014-2019)
12.3.5 GlaxoSmithKline Recent Development
12.4 Novartis AG
12.4.1 Novartis AG Company Details
12.4.2 Company Description and Business Overview
12.4.3 Chronic Obstructive Pulmonary Disease (COPD) Treatment Introduction
12.4.4 Novartis AG Revenue in Chronic Obstructive Pulmonary Disease (COPD) Treatment Business (2014-2019)
12.4.5 Novartis AG Recent Development
12.5 Teva Pharmaceutical Industries
12.5.1 Teva Pharmaceutical Industries Company Details
12.5.2 Company Description and Business Overview
12.5.3 Chronic Obstructive Pulmonary Disease (COPD) Treatment Introduction
12.5.4 Teva Pharmaceutical Industries Revenue in Chronic Obstructive Pulmonary Disease (COPD) Treatment Business (2014-2019)
12.5.5 Teva Pharmaceutical Industries Recent Development
12.6 Sunovion Pharmaceuticals
12.6.1 Sunovion Pharmaceuticals Company Details
12.6.2 Company Description and Business Overview
12.6.3 Chronic Obstructive Pulmonary Disease (COPD) Treatment Introduction
12.6.4 Sunovion Pharmaceuticals Revenue in Chronic Obstructive Pulmonary Disease (COPD) Treatment Business (2014-2019)
12.6.5 Sunovion Pharmaceuticals Recent Development
12.7 CHIESI Farmaceutici
12.7.1 CHIESI Farmaceutici Company Details
12.7.2 Company Description and Business Overview
12.7.3 Chronic Obstructive Pulmonary Disease (COPD) Treatment Introduction
12.7.4 CHIESI Farmaceutici Revenue in Chronic Obstructive Pulmonary Disease (COPD) Treatment Business (2014-2019)
12.7.5 CHIESI Farmaceutici Recent Development
12.8 Orion Corporation
12.8.1 Orion Corporation Company Details
12.8.2 Company Description and Business Overview
12.8.3 Chronic Obstructive Pulmonary Disease (COPD) Treatment Introduction
12.8.4 Orion Corporation Revenue in Chronic Obstructive Pulmonary Disease (COPD) Treatment Business (2014-2019)
12.8.5 Orion Corporation Recent Development
12.9 ​Mylan
12.9.1 ​Mylan Company Details
12.9.2 Company Description and Business Overview
12.9.3 Chronic Obstructive Pulmonary Disease (COPD) Treatment Introduction
12.9.4 ​Mylan Revenue in Chronic Obstructive Pulmonary Disease (COPD) Treatment Business (2014-2019)
12.9.5 ​Mylan Recent Development

13 Market Forecast 2019-2025
13.1 Market Size Forecast by Product (2019-2025)
13.2 Market Size Forecast by Application (2019-2025)
13.3 Market Size Forecast by Regions
13.4 North America
13.5 Europe
13.6 China
13.7 Japan
13.8 Southeast Asia
13.9 India
13.10 Central & South America

14 Analyst’s Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details



【掲載企業】

AstraZeneca、Boehringer Ingelheim International GmbH、GlaxoSmithKline、Novartis AG、Teva Pharmaceutical Industries、Sunovion Pharmaceuticals、CHIESI Farmaceutici、Orion Corporation、​Mylan

★調査レポート[慢性閉塞性肺疾患(COPD)治療の世界市場:規模・現状・予測2019-2025] (コード:QYR20FB14393)販売に関する免責事項を必ずご確認ください。
★調査レポート[慢性閉塞性肺疾患(COPD)治療の世界市場:規模・現状・予測2019-2025]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆